This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
JCR Pharmaceuticals Co., Ltd.
Drug Names(s): BBB-Penetrating IDS
Description: JR-141 is a compound targeting BBB-Penetrating Iduronate-2-sulfatase. It was developed using JCR's proprietary Blood-Brain Barrier Penetrating Technology and High-level Protein Expression System.
Additional information available to subscribers only: